Researchers from Duke-NUS Medical School, Singapore have uncovered a potential mechanism behind cancer suppression in ba...
A*STAR, Singapore, on 1 July 2019, announced that the National Research Foundation (NRF) has awarded Singapore Immunolog...
NUS Synthetic Biology for Clinical & Technological Innovation (NUS SynCTI) is a focal research programme at the...
In celebration of National Cancer Survivors Day, AstraZeneca, a global, science-led biopharmaceutical company, on 27 Jun...
The Singapore’s drug development efforts have been given additional momentum with the introduction of Experimental...
Doctors may one day be able to diagnose Alzheimer’s disease (AD), the most common cause of severe dementia, and mo...
Thunes (previously TransferTo), a B2B global payments platform for emerging markets, on 25 June 2019, announced KB ...
Gilead Sciences, Inc., on 24 June 2019, announced that the Singapore Health Sciences Authority (HAS) has approved Vosevi...
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluati...
Novena Global Lifecare, an integrated healthcare platform in over 250 clinics and sales locations and one of the largest...
SingHealth, the largest public healthcare cluster in Singapore, has received a $40 million gift from Ngee Ann...
A new research study by Duke-NUS Medical School, Singapore, on 18 June 2019, describes the process of activation and gen...
A third (34 per cent) of eczema management mobile applications provide information that does not agree with internationa...
Zuellig Pharma has acquired Singapore-based Healthtech start-up Klinify, to support the development of technology that e...
Tessa Therapeutics (Tessa), a clinical-stage cell therapy company focused on the development of autologous and allogenei...
FedEx Express, a subsidiary of FedEx Corp. and the world's largest express transportation company, on 10 June 2019, has ...
Singapore based Proteona Pte. Ltd., on 10 June 2019, announced the launch of its latest ESCAPE™ proteogenomics ass...
Singapore headquartered TauRx, a leader in neurodegenerative disease research, received the Frost & Sullivan's 2019 ...
